External validation of four breast cancer risk prediction models for personalized screening in a prospective Dutch screening cohort

Jim Peters; Daniëlle van der Waal; Marjanka K. Schmidt; Carla H. van Gils; Mireille J. M. Broeders; On behalf of the PRISMA consortium; Mireille Broeders; Loes Dunning; Carla van Gils; Nico Karssemeijer; Harry de Koning; Marja van Oirsouw; Nicolien van Ravesteyn; Marjanka Schmidt; Ellen Verschuur; Daniëlle van der Waal

doi:10.1038/s41523-026-01017-9

External validation of four breast cancer risk prediction models for personalized screening in a prospective Dutch screening cohort

npj Breast Cancer · Published 2026-07-31 · DOI 10.1038/s41523-026-01017-9

Authors (16)

Jim Peters, Daniëlle van der Waal, Marjanka K. Schmidt, Carla H. van Gils, Mireille J. M. Broeders, On behalf of the PRISMA consortium, Mireille Broeders, Loes Dunning, Carla van Gils, Nico Karssemeijer, Harry de Koning, Marja van Oirsouw, Nicolien van Ravesteyn, Marjanka Schmidt, Ellen Verschuur, Daniëlle van der Waal

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Citation

Peters, J., Waal, D., Schmidt, M., et al. (2026). External validation of four breast cancer risk prediction models for personalized screening in a prospective Dutch screening cohort. npj Breast Cancer. https://doi.org/10.1038/s41523-026-01017-9

Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete response · npj Breast Cancer · 2026 · Same journal
Anlotinib-containing regimens in HR+ advanced breast cancer after prior CDK4/6 inhibitor progression · npj Breast Cancer · 2026 · Same journal
Clinical significance of residual microcalcifications after neoadjuvant chemotherapy: MRI response and the subtypes · npj Breast Cancer · 2026 · Same journal
Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial · npj Breast Cancer · 2026 · Same journal
Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring · npj Breast Cancer · 2026 · Same journal
Facing death: the last drawings of a woman with breast cancer at the end of life · npj Breast Cancer · 2026 · Same journal
Impact of neoadjuvant chemotherapy on local breast microbiota and macrophages in ER-positive breast cancer with links to treatment response · npj Breast Cancer · 2026 · Same journal
PCSK9 rs562556 variant and survival in BRCA1 mutation carriers and mutation-negative familial breast cancer · npj Breast Cancer · 2026 · Same journal
Patient-reported outcomes as early indicators of recurrence, disease progression, and survival via machine learning in breast cancer · npj Breast Cancer · 2026 · Same journal
Predicting early-stage breast cancer disease-free survival and adjuvant therapy benefit from multimodal information using deep learning · npj Breast Cancer · 2026 · Same journal

External validation of four breast cancer risk prediction models for personalized screening in a prospective Dutch screening cohort

Authors (16)

Abstract

Publication details

Citation

Related articles